Arcturus Therapeutics Holdings Inc.ARCTNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P14
Within normal range
vs 5Y Ago
-0.6x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -42.50% |
| 2024 | 1.57% |
| 2023 | 30.04% |
| 2022 | -14.97% |
| 2021 | 200.38% |
| 2020 | 71.96% |
| 2019 | 98.09% |
| 2018 | 6.68% |
| 2017 | -13.45% |
| 2016 | 36.62% |